Login

744P Safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of adebrelimab: A phase I trial

0301 basic medicine 03 medical and health sciences
DOI: 10.1016/j.annonc.2022.07.870 Publication Date: 2022-09-13T18:50:37Z
Abstract Supplemental Material References Cited by
AUTHORS (5)
X. Hu
Y. Fan
W. Jing
Y. Shen
X. Ma
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
OPENAIRE - Products  CROSSREF - Publications 
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....